Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors.
about
Vaccines: from empirical development to rational designA glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primatesFusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates.Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40L signaling through the mTORC1 pathwayThe influence of delivery vectors on HIV vaccine efficacyImmune responses in macaques to a prototype recombinant adenovirus live oral human papillomavirus 16 vaccine.Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizationsThe sero-prevalence of anti-adenovirus 5 neutralizing antibodies is independent of a chronic hepatitis B carrier state in ChinaComparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors.Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization.A new model for CD8+ T cell memory inflation based upon a recombinant adenoviral vector.Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8(+) T-cell responses to anticancer vaccinesModeling pre-existing immunity to adenovirus in rodents: immunological requirements for successful development of a recombinant adenovirus serotype 5-based ebola vaccine.Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection.Recent advances in molecular medicine techniques for the diagnosis, prevention, and control of infectious diseases.Improving T cell-induced response to subunit vaccines: opportunities for a proteomic systems approach.Adenovirus Serotype 5 Vaccination Results in Suboptimal CD4 T Helper 1 Responses in MiceTG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice.Recombinant adenovirus expressing the haemagglutinin of Peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR.
P2860
Q21089599-9E367850-C792-4135-80AB-6ECCDE3BAA5DQ27303293-B476EA4E-8BC1-4535-B25D-BB2DC74495BBQ33586992-EF88A664-1337-4DC7-8A9B-0A85E8C0AD92Q33920141-CF8E713A-628E-4277-BCA8-709CF12AB353Q34077543-74F787FF-3645-45D4-8FB1-ABE3ABD1F9B0Q34260720-102A1AB1-775C-4AE9-9AFC-0AEDCE57D4F6Q34593874-DDD16BA8-D6E9-420C-BFCA-0B5E8314D3D5Q35204923-AFFB8AB7-EFEA-4808-87F7-8D0D0A99FEFEQ36559772-D526CB81-3598-4998-84AF-E40F750E19C7Q36674446-28ED4827-01A3-43D8-8587-A6F44CC754CDQ36903875-F50A120D-41CB-4517-BE85-BA1217F3181BQ37196054-BD2BF349-F9B3-462F-B9E1-6675E42577B0Q37627897-6670FC66-79BC-46CD-A5E2-CAB8F0C3F612Q37644059-700BE336-2EBF-4E86-B258-E8BA109D88DDQ38075857-F550EDF3-3E67-46ED-9DF1-0CF4F53C7653Q38364597-67684962-BE84-4D6A-A101-98EA4DDE3FEEQ40399897-AB1DCDDC-E885-46AF-B991-EAACCCA7E911Q41646089-26AC7C89-4634-47AF-8C82-84136FA91184Q41995734-D8E4E5C4-FD8F-4051-91A5-E379686BB9C2
P2860
Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Optimizing vaccine-induced CD8
@nl
Optimizing vaccine-induced CD8 ...... ecombinant adenovirus vectors.
@en
type
label
Optimizing vaccine-induced CD8
@nl
Optimizing vaccine-induced CD8 ...... ecombinant adenovirus vectors.
@en
prefLabel
Optimizing vaccine-induced CD8
@nl
Optimizing vaccine-induced CD8 ...... ecombinant adenovirus vectors.
@en
P2860
P356
P1476
Optimizing vaccine-induced CD8 ...... ecombinant adenovirus vectors.
@en
P2093
Jennifer D Bassett
Stephanie L Swift
P2860
P304
P356
10.1586/ERV.11.88
P577
2011-09-01T00:00:00Z